This means we now have a further $30 million cash in the bank. I'm guessing it must be going towards productions lines in the near future and hopefully they are for an Amgen drug/device combo that they've been working on for 3 years.
This is the most frustrating company I've ever owned but I've learnt about about myself holding it all these years. When it's good it's great with UNS.
I'm in no hurry to sell out, after the AMGEN announcement I realised the way it was structured wouldn't provide a sugar hit but was set up to assist the company throughout the future. My timeframe was reset on my holding period but I honestly can see the day that this company turns a profit and then adds consistent and incremental profit year after year.
Still a while off but I'm looking forward to it
UNS Price at posting:
19.5¢ Sentiment: Buy Disclosure: Held